Becton, Dickinson and Co. | BDX - Current Liabilities

Stock Price
152.14
Daily Change
-2.71 -1.75%
Monthly
-3.87%
Yearly
-25.81%
Q2 Forecast
148.88

Becton, Dickinson and Co. reported $8.76B in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Abbott USD 16.5B 1.91B Dec/2025
Agilent USD 2.23B 113M Dec/2025
Align Technology USD 1.92B 46.45M Dec/2025
AngioDynamics USD 71.96M 3.68M Sep/2025
Avanos Medical USD 165.2M 17.3M Dec/2025
Baxter International USD 2.97B 805M Dec/2025
Becton, Dickinson and Co. USD 8.76B 448M Dec/2025
Bio-Rad Laboratories USD 517M 5.3M Dec/2025
Boston Scientific USD 5.44B 111M Dec/2025
Cooper Companies USD 1.6B 482.9M Dec/2025
Danaher USD 7.46B 653M Mar/2026
Dentsply International USD 1.34B 62M Dec/2025
Dexcom USD 2.14B 1.19B Dec/2025
Edwards Lifesciences USD 1.81B 225.7M Dec/2025
Globus Medical USD 498.5M 32.54M Dec/2025
Insulet USD 680.1M 32.4M Dec/2025
Integra LifeSciences USD 455.98M 91.93M Dec/2025
Intuitive Surgical USD 2.51B 3.2M Mar/2026
J&J USD 57.72B 3.59B Mar/2026
Masimo USD 371.6M 1.9M Dec/2025
Medtronic USD 9.5B 440M Dec/2025
Solventum Corp USD 3.14B 198M Dec/2025
Stryker USD 7.79B 380M Dec/2025
Tandem Diabetes Care USD 242.72M 9.82M Dec/2025
Teleflex USD 762.03M 11.01M Dec/2025
Terumo JPY 539.7B 243.4B Dec/2025
Thermo Fisher Scientific USD 14.62B 568M Mar/2026
Zimmer Biomet Holdings USD 2.58B 180.8M Dec/2025